Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
27.58 SEK | +1.03% | -12.44% | +81.45% |
May. 14 | Moberg Pharma AB Elects Jonas Ekblom as Board Member | CI |
May. 07 | Moberg Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 6M 559K | Sales 2025 * | 42M 3.91M | Capitalization | 763M 71.14M |
---|---|---|---|---|---|
Net income 2024 * | -29M -2.7M | Net income 2025 * | -22M -2.05M | EV / Sales 2024 * | 127 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 18.2 x |
P/E ratio 2024 * |
-39
x | P/E ratio 2025 * |
-39
x | Employees | 10 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 68.14% |
1 day | +2.12% | ||
1 week | -11.49% | ||
Current month | -18.34% | ||
1 month | -5.49% | ||
3 months | +85.87% | ||
6 months | +244.20% | ||
Current year | +83.42% |
Managers | Title | Age | Since |
---|---|---|---|
Anna Ljung
CEO | Chief Executive Officer | 44 | 05-12-31 |
Mark Beveridge
DFI | Director of Finance/CFO | 46 | 14-12-31 |
Chief Tech/Sci/R&D Officer | 60 | 22-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anders Lundmark
BRD | Director/Board Member | 66 | 22-05-15 |
Håkan Wallin
BRD | Director/Board Member | 62 | 23-05-15 |
Nikolaj Sørensen
BRD | Director/Board Member | 52 | 20-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 27.58 | +1.03% | 123 124 |
24-05-16 | 27.3 | +3.33% | 459,236 |
24-05-15 | 26.42 | -5.78% | 646,235 |
24-05-14 | 28.04 | +0.65% | 536,549 |
24-05-13 | 27.86 | -11.56% | 1,942,041 |
Delayed Quote Nasdaq Stockholm, May 17, 2024 at 04:22 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+83.42% | 71.33M | |
+32.36% | 694B | |
+30.24% | 593B | |
-1.60% | 371B | |
+20.07% | 331B | |
+6.04% | 290B | |
+14.36% | 239B | |
+10.22% | 209B | |
-3.03% | 209B | |
+9.27% | 169B |
- Stock Market
- Equities
- MOB Stock